Literature DB >> 17229947

The preventive polypill--much promise, insufficient evidence.

K Srinath Reddy1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17229947     DOI: 10.1056/NEJMp068219

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  11 in total

Review 1.  What is the future of stroke prevention?: debate: polypill versus personalized risk factor modification.

Authors:  Walter N Kernan; Lenore J Launer; Larry B Goldstein
Journal:  Stroke       Date:  2010-10       Impact factor: 7.914

Review 2.  Medication adherence in heart failure.

Authors:  Paul J Hauptman
Journal:  Heart Fail Rev       Date:  2007-05-04       Impact factor: 4.214

3.  New prescription medication gaps: a comprehensive measure of adherence to new prescriptions.

Authors:  Andrew J Karter; Melissa M Parker; Howard H Moffet; Ameena T Ahmed; Julie A Schmittdiel; Joe V Selby
Journal:  Health Serv Res       Date:  2009-06-03       Impact factor: 3.402

Review 4.  Novel treatments for cardiovascular disease prevention.

Authors:  Mark D Huffman; Deepak Bhatnagar
Journal:  Cardiovasc Ther       Date:  2011-05-31       Impact factor: 3.023

5.  Developing therapies for the metabolic syndrome: challenges, opportunities, and… the unknown.

Authors:  Glenn Matfin
Journal:  Ther Adv Endocrinol Metab       Date:  2010-04       Impact factor: 3.565

6.  Polypill for the prevention of cardiovascular disease (PolyIran): study design and rationale for a pragmatic cluster randomized controlled trial.

Authors:  Mohammad Reza Ostovaneh; Hossein Poustchi; Karla Hemming; Hajiamin Marjani; Akram Pourshams; Alireza Nateghi; Masoud Majed; Behrouz Navabakhsh; Masoud Khoshnia; Elham Jaafari; Noushin Mohammadifard; Fatemeh Malekzadeh; Shahin Merat; Masoumeh Sadeghi; Mohammad Naemi; Arash Etemadi; G Neil Thomas; Nizal Sarrafzadegan; K K Cheng; Tom Marshall; Reza Malekzadeh
Journal:  Eur J Prev Cardiol       Date:  2014-09-17       Impact factor: 7.804

7.  [Medication adherence in patients with chronic diseases: significance and new approaches].

Authors:  U Laufs
Journal:  Nervenarzt       Date:  2011-02       Impact factor: 1.214

Review 8.  Challenges in developing drugs for the metabolic syndrome.

Authors:  Glenn Matfin
Journal:  Curr Diab Rep       Date:  2008-02       Impact factor: 4.810

Review 9.  Compliance and fixed-dose combination therapy.

Authors:  Sripal Bangalore; Anupama Shahane; Sanobar Parkar; Franz H Messerli
Journal:  Curr Hypertens Rep       Date:  2007-06       Impact factor: 4.592

10.  Fixed drug combination in hypertension and hyperlipidaemia in the developing world.

Authors:  Y K Seedat
Journal:  Cardiovasc J Afr       Date:  2008 May-Jun       Impact factor: 1.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.